ResearcherLMU KlinikumNo recent work listed

Najib Ben Khaled

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9681-2542; OpenAlex author ID A5013072773. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status. Co-author DOI 10.3390/cancers14215240 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ignazio Piseddu · 1 shared paper, 2022 · strength 0.13
- Paper TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation… DOI 10.3390/cancers14215240 ↗
Simon Sirtl · 1 shared paper, 2022 · strength 0.13
- Paper TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation… DOI 10.3390/cancers14215240 ↗
Enrico Narciso De Toni · 1 shared paper, 2022 · strength 0.13
- Paper TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation… DOI 10.3390/cancers14215240 ↗
Julia V. Mayerle · 1 shared paper, 2022 · strength 0.13
- Paper TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation… DOI 10.3390/cancers14215240 ↗
Ujjwal Mukund Mahajan · 1 shared paper, 2022 · strength 0.13
- Paper TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation… DOI 10.3390/cancers14215240 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.